Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 60505-2579

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60505-2579). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

→ Figure-01 (figure 01)

→ Figure-02 (figure 02)

→ Figure-03 (figure 03)

→ Btl-lbl-10mg-90s.jpg (btl Lbl 10mg 90s)

→ Btl-lbl-20mg-90s.jpg (btl Lbl 20mg 90s)

→ Btl-lbl-40mg-90s.jpg (btl Lbl 40mg 90s)

→ Btl-lbl-80mg-90s.jpg (btl Lbl 80mg 90s)

→ Chemical-structure (chemical Structure)

FDA Label Image

Figure-01 (Figure 01)

FDA Label Image

Figure-02 (Figure 02)

The text seems to be a survival analysis plot showing the cumulative hazard percentage of a certain drug (Atorvastatin) compared to a placebo. The hazard ratio (HR) between the two groups is 0.53 with a confidence interval of 0.45 to 0.83. The X-axis displays the time to the first primary endpoint up to four years of follow-up.*

FDA Label Image

Figure-03 (Figure 03)

The text appears to be a chart or graph showing the percentage of subjects experiencing vertigo with Horvastatin 10 mg and Sorvastatin 80 mg. The graph also includes statistical information with HR values and P-values. There is also a mention of a "Major Cardiovascular Endpoirt" (likely "Endpoint") and a time frame in years. It is not possible to fully understand the information presented without additional context or visual representation of the graph.*

FDA Label Image